1 Report Prologue
2 Market Introduction
2.1 Definition…………………………………………………………………….…………………...14
2.2 Scope Of Study……………………………………………….………….………………………14
2.3 Research Objective……………………………………………………………..………………14
2.4 Assumptions & Limitations……………………………………………………………………..15
2.4.1 Assumptions……………………………………………………………………………15
2.4.2 Limitations………………………………………………………………………………15
2.5 Market Structure…………………………………………………………………………………15
3 Research Methodology
3.1 Primary Research Methodology……………………………………………………………….17
3.2 Secondary Research Methodology……………………………………………………………18
3.3 Market Share Analysis………………………………………………………………………….19
3.4 Market Pricing Approach……………………………………………………………………….19
4 Market Dynamics
4.1 Introduction………………………………………………………………………………………20
4.2 Drivers…………………………………………………………………………………………….21
4.2.1 Increasing Prevalence Of Respiratory Tract Diseases……………………………….21
4.2.2 Increase In Preference For Minimally Invasive Procedures………………………...22
4.2.3 Increasing Number Of Bronchoscopies Procedures………………………………...23
4.3 Restraints………………………………………………………………………………………...24
4.3.1 High Cost Of The Bronchoscopes……………………………………………………...24
4.3.2 Increasing Incident Of Infection By Bronchoscopes…………………………………25
4.4 Opportunities…………………………………………………………………………………….26
4.4.1 Increasing Adoption Of Bronchoscopes……………………………………………...26
4.5 Mega Trends……………………………………………………………………………………..26
4.5.1 Adoption Of Video Technology…………………………………………………………26
4.6 Macroeconomic Indicators……………………………………………………………………..26
4.7 Technological Trends……………………………………………………………………………27
4.7.1 Incorporation Of The Auto Fluorescence Imagining And Narrow Band Imaging In Bronchoscopes…………………………………………………………………………27
5 Market Factor Analysis
5.1 Supply Chain Analysis………………………………………………………………………….28
5.1.1 Raw Material……………………………………………………………………………29
5.1.2 Supplier…………………………………………………………………………………29
5.1.3 Manufacturer……………………………………………...……………………………31
5.1.4 Distributor………………………………………………………………………………31
5.1.5 Customer…………………………………………………….…………………………31
5.1.6 Consumer………………………………………………………………………………32
5.2 Porter’s Five Forces Model……………………………….……………………………………33
5.2.1 Bargaining Power Of Suppliers…………………………………..……………………33
5.2.2 Bargaining Power Of Buyers……………………………………….…………………34
5.2.3 Threat Of New Entrants…………………………………….…………………………34
5.2.4 Threat Of Substitutes………………………………………….………………………34
5.2.5 Intensity Of Rivalry…………………………………………….………………………34
5.3 Investment Opportunity Analysis………………………………………………………………35
5.4 Country Wise Pricing Of Bronchoscopes (Top 7 Countries)…………………..……………35
5.5 Number Of Bronchoscopy Procedures Carried Out Across The Globe (2020-2027) ……36
6 Global Bronchoscopes Market By Type
6.1 Introduction………………………………………………………………………………………37
6.2 Rigid Bronchoscopes……………………………………………………………………………39
6.3 Flexible Bronchoscopes ………………………………………………..………………………40
6.3.1 Fiber Optic Bronchoscopes…………………………..………………………………41
6.3.2 Video Bronchoscopes…………………………………………………………………42
7 Global Bronchoscopes Market By Application
7.1 Introduction………………………………………………………………………………………43
7.2 Diagnosis………………………………………………………...………………………………45
7.2.1. Examination…………………………………………….………………………………45
7.2.1.1 Patient’s Airways………………….……..…………………………………...45
7.2.1.2 Bleeding Lungs………………….……………………………………………45
7.2.1.3 Possibility Of Lung Cancer…….…….………..……………………………..46
7.2.1.4 Chronic Cough………………..……….……………………………………46
7.2.2 Obtain Tissue Specimen For Biopsy…………………………………………………46
7.3 Surgical Procedure………………………………………………………...……………………47
7.3.1 Removal Of A Foreign Object In The Airway……………………………..……………47
7.3.2 Laser Resection Of Tumors……………………………………………………………47
7.3.3 Lung Abscess……………………………………………..……………………………47
7.3.4 Stent Insertion……………………………………………………………….…………47
7.3.5 Percutaneous Tracheostomy…………………………………………………………48
7.3.6 Tracheal Intubation…………………………………………….………………………48
8 Global Bronchoscopes Market By End User
8.1 Introduction………………………………………………………………………………………49
8.2 Hospitals & Clinics………………………………………………………………………………50
8.3 Diagnostic Centers………………………………………………………………………………51
8.4 Others…………………………………………………………………………….………………51
9 Global Bronchoscopes Market, By Region
9.1 Introduction………………………………………………………………………………………52
9.2 Americas………………………………………………………………………………………….54
9.2.1 North America………………………………………………………………………….58
9.2.1.1 U.S. ……………………………………………………………………………60
9.2.1.2 Canada………………………………………………………………………..62
9.2.2 South America………………………………………………………………………….64
9.3 Europe……………………………………………………………………………………………67
9.3.1 Western Europe………………………………………………………………………..72
9.3.1.1 Germany………………………………………………………………………74
9.3.1.2 France…………………………………………………………………………76
9.3.1.3 U.K.……………………………………………………………………………78
9.3.1.4 Italy……………………………………………………………………………80
9.3.1.5 Spain………………………………………………………………………….82
9.3.1.6 Rest Of Western Europe ……………………………………………………84
9.3.2 Eastern Europe………………………………………………………………………..86
9.4 Asia Pacific………………………………………………………………………………………89
9.4.1 Japan……………………………………………………………………………………92
9.4.2 China………………………………………………………………………………...….94
9.4.3 India……………………………………………………………………………………..96
9.4.4 Republic Of Korea……………………………………………………………………..98
9.4.5 Australia……………………………………………………………………………….100
9.4.6 Rest Of Asia Pacific……………………………………………………………………………………..…….102
9.5 Middle East & Africa………………………………………………..………………………….105
9.5.1 Middle East……………………………………………..…………………………….108
9.5.2 Africa…………………………………………………………………………………..110
10 Company Landscape
10.1 Introduction………………………………………………………………………………..……113
10.2 Company Share Analysis………………………………………………………………..……113
10.3 Key Developments……………………………………………………………………….……115
11 Company Profile
11.1 Boston Scientific Corporation…………………………………………………………………117
11.1.1 Company Overview…………………………………………………………………..117
11.1.2 Financials……………………………………………………………………………117
11.1.3 Products……………………………………………………………………………..117
11.1.4 Products……………………………………………………………………………..117
11.1.5 Key Developments………………………………………………………………….117
11.2 Ambu Inc………………………………………………………………………………………118
11.2.1 Company Overview………………………………………………………………...118
11.2.2 Financials……………………………………………………………………………118
11.2.3 Products……………………………………………………………………………..118
11.2.4 Strategy………………………………………………………………………………118
11.2.5 Key Developments………………………………………………………………….118
11.3 Cogentix Medical……………………………………………………………………………..119
11.3.1 Company Overview………………………………………………………………...119
11.3.2 Financials……………………………………………………………………………119
11.3.3 Products…………………………………………………………………………….119
11.3.4 Strategy……………………………………………………………………………..119
11.3.5 Key Developments…………………………………………………………………119
11.4 Fujifilm Holdings Corporation……………………………………………………………….120
11.4.1 Company Overview………………………………………………………………...120
11.4.2 Financials…………………………………………………………………………….120
11.4.3 Products………………………………………………………………………………120
11.4.4 Strategy………………………………………………………………………………120
11.4.5 Key Developments………………………………………………………………….120
11.5 Olympus Corporation………………………………………………………………………...121
11.5.1 Company Overview………………………………………………………………...121
11.5.2 Financials……………………………………………………………………………121
11.5.3 Products……………………………………………………………………………..121
11.5.4 Strategy………………………………………………………………………………121
11.5.5 Key Developments………………………………………………………………….121
11.6 PENTAX Medical…………………………………………………………………………….122
11.6.1 Company Overview………………………………………………………………...122
11.6.2 Financials……………………………………………………………………………122
11.6.3 Products……